Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFSAN Visiting Supplement Companies For Information On Developing GMPs

This article was originally published in The Tan Sheet

Executive Summary

FDA representatives have visited three dietary supplement manufacturing facilities the last two months and will visit three more the week of Sept. 30 to better understand the manufacturing practices of the supplement industry. The information gathered during the visits will be used as the agency develops its proposed rule for dietary supplement Good Manufacturing Practices.

You may also be interested in...



Supplement GMPs Should Proceed Despite Economic Concerns - CRN, Rexall

Concerns over the economic burden that small companies will face when implementing Good Manufacturing Practices for dietary supplements should not delay or unduly affect FDA's rulemaking, industry commenters advise.

Supplement GMPs Should Proceed Despite Economic Concerns - CRN, Rexall

Concerns over the economic burden that small companies will face when implementing Good Manufacturing Practices for dietary supplements should not delay or unduly affect FDA's rulemaking, industry commenters advise.

Supplement GMPs Should Proceed Despite Economic Concerns - CRN, Rexall

Concerns over the economic burden that small companies will face when implementing Good Manufacturing Practices for dietary supplements should not delay or unduly affect FDA's rulemaking, industry commenters advise.

Related Content

Topics

UsernamePublicRestriction

Register

PS090326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel